Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Behav Immun ; 73: 340-351, 2018 10.
Article in English | MEDLINE | ID: mdl-29787857

ABSTRACT

Diseases, disorders, and insults of aging are frequently studied in otherwise healthy animal models despite rampant co-morbidities and exposures among the human population. Stressor exposures can increase neuroinflammation and augment the inflammatory response following a challenge. The impact of dietary exposure on baseline neural function and behavior has gained attention; in particular, a diet high in fructose can increase activation of the hypothalamic-pituitary-adrenal axis and alter behavior. The current study considers the implications of a diet high in fructose for neuroinflammation and outcomes following the cerebrovascular challenge of stroke. Ischemic injury may come as a "second hit" to pre-existing metabolic pathology, exacerbating inflammatory and behavioral sequelae. This study assesses the neuroinflammatory consequences of a peri-adolescent high-fructose diet model and assesses the impact of diet-induced metabolic dysfunction on behavioral and neuropathological outcomes after middle cerebral artery occlusion. We demonstrate that consumption of a high-fructose diet initiated during adolescent development increases brain complement expression, elevates plasma TNFα and serum corticosterone, and promotes depressive-like behavior. Despite these adverse effects of diet exposure, peri-adolescent fructose consumption did not exacerbate neurological behaviors or lesion volume after middle cerebral artery occlusion.


Subject(s)
Depression/etiology , Depression/metabolism , Fructose/adverse effects , Age Factors , Animals , Behavior, Animal/physiology , Brain/pathology , Corticosterone/analysis , Corticosterone/blood , Depression/physiopathology , Diet, High-Fat/adverse effects , Disease Models, Animal , Fructose/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Infarction, Middle Cerebral Artery/physiopathology , Male , Neuroimmunomodulation/drug effects , Pituitary-Adrenal System/physiopathology , Rats , Rats, Wistar , Stress, Psychological/metabolism , Stroke/pathology , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/blood
2.
J Basic Microbiol ; 58(1): 17-29, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29141107

ABSTRACT

Microorganisms can modify the chemical and physical characters of metals leading to an alteration in their speciation, mobility, and toxicity. Aqueous heavy metals solutions (Hg, Cd, Pb, Ag, Cu, and Zn) were treated with the volatile metabolic products (VMPs) of Escherichia coli Z3 for 24 h using aerobic bioreactor. The effect of the metals treated with VMPs in comparison to the untreated metals on the growth of E. coli S1 and Staphylococcus aureus S2 (local isolates) was examined. Moreover, the toxic properties of the treated and untreated metals were monitored using minimum inhibitory concentration assay. A marked reduction of the treated metals toxicity was recorded in comparison to the untreated metals. Scanning electron microscopy and energy dispersive X-ray analysis revealed the formation of metal particles in the treated metal solutions. In addition to heavy metals at variable ratios, these particles consisted of carbon, oxygen, sulfur, nitrogen elements. The inhibition of metal toxicity was attributed to the existence of ammonia, hydrogen sulfide, and carbon dioxide in the VMPs of E. coli Z3 culture that might responsible for the transformation of soluble metal ions into metal complexes. This study clarified the capability of E. coli Z3 for indirect detoxification of heavy metals via the immobilization of metal ions into biologically unavailable species.


Subject(s)
Bacteria/metabolism , Escherichia coli/metabolism , Metals, Heavy/metabolism , Bioreactors , Chelating Agents , Mercury/metabolism , Microbial Sensitivity Tests , Staphylococcus aureus/metabolism , Volatilization , Water/chemistry
3.
Neuroscience ; 239: 92-102, 2013 Jun 03.
Article in English | MEDLINE | ID: mdl-23079632

ABSTRACT

We investigated the effect of delayed, prolonged systemic inflammation on stroke outcomes and progesterone (P4) neuroprotection in middle-aged rats. After transient middle cerebral artery occlusion/reperfusion (MCAO) surgery, rats received P4 (8 or 16 mg/kg) or vehicle injections at 2h, 6h and every 24h until day 7 post-occlusion. At 24h post-injury systemic inflammation was induced by giving three doses of lipopolysaccharide (LPS; 50 µg/kg, at 4h intervals) to model post-stroke infections. We measured serum brain-derived neurotrophic factor (BDNF), pro-inflammatory cytokines, and behavioral parameters at multiple times. Serum BDNF levels decreased more in the vehicle+LPS group compared to vehicle-alone at 3 and 7 days post-injury (P<0.05). Vehicle-alone showed a significant increase in interleukin-1ß, interleukin-6, and tumor necrosis factor alpha levels at different times following stroke and these levels were further elevated in the vehicle+LPS group. P4 at both doses produced a significant (P<0.05) decline in cytokine levels compared to vehicle and vehicle+LPS. P4 restored BDNF levels at 3 and 7 days post-stroke (P<0.05). Behavioral assessment (rotarod, grip strength, sensory neglect and locomotor activity tests) at 3, 5 and 7 days post-stroke revealed that the vehicle group had significant (P<0.05) deficits in all tests compared to intact controls, and performance was worse in the vehicle+LPS group. P4 at both doses produced significant functional improvement on all tests. Systemic inflammation did not show an additive effect on infarct volume but P4 at both doses showed significant infarct reduction. We suggest that post-stroke infection exacerbates stroke outcomes and P4 exerts neuroprotective/modulatory effects through its systemic anti-inflammatory and BDNF regulatory actions.


Subject(s)
Inflammation/complications , Neuroprotective Agents/pharmacology , Progesterone/pharmacology , Stroke/complications , Stroke/pathology , Animals , Brain Ischemia/complications , Brain Ischemia/pathology , Brain-Derived Neurotrophic Factor/analysis , Brain-Derived Neurotrophic Factor/metabolism , Cytokines/analysis , Cytokines/metabolism , Inflammation/chemically induced , Inflammation/pathology , Lipopolysaccharides/toxicity , Male , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects
4.
Neuroscience ; 210: 442-50, 2012 May 17.
Article in English | MEDLINE | ID: mdl-22450229

ABSTRACT

We tested the hypothesis that the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway mediates some of the neuroprotective effects of progesterone (PROG) after ischemic stroke. We examined whether PROG acting through the PI3K/Akt pathway could affect the expression of vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF). Rats underwent permanent focal cerebral ischemia by electrocoagulation and received intraperitoneal injections of PROG (8 mg/kg) or vehicle at 1 h post-occlusion and subcutaneous injections at 6, 24, and 48 h. PAkt/Akt levels, apoptosis and apoptosis-related proteins (phosphorylated Bcl-2-associated death promoter (pBAD), BAD, caspase-3, and cleaved caspase-3) were analyzed by TUNEL assays, Western blotting and immunohistochemistry at 24 h post-pMCAO. VEGF and BDNF were analyzed at 24, 72 h and 14 days post-pMCAO with Western blots. Following pMCAO, PROG treatment significantly (P<0.05) reduced ischemic lesion size and edema. Treatment with PROG significantly (P<0.05) decreased VEGF at 24 and 72 h but increased VEGF expression 14 days after injury. The treatment also increased BDNF, and attenuated apoptosis by increasing Akt phosphorylation compared with vehicle alone. The selective PI3K inhibitor wortmannin compromised PROG-induced neuroprotective effects and reduced the elevation of pAkt levels in the ischemic penumbra. Our findings lead us to suggest that the PI3K/Akt pathway can play a role in mediating the neuroprotective effects of PROG after stroke by altering the expression of trophic factors in the brain.


Subject(s)
Brain Ischemia/metabolism , Brain/drug effects , Neuroprotective Agents/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Progesterone/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Animals , Blotting, Western , Brain/metabolism , Brain Injuries/drug therapy , Brain Injuries/metabolism , Brain Ischemia/drug therapy , Immunohistochemistry , In Situ Nick-End Labeling , Male , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects
5.
Hum Exp Toxicol ; 22(9): 473-80, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14580007

ABSTRACT

Walnut (Juglans regia L.) is extensively used in traditional systems of medicine for treatment of various ailments. It is described as an anticancer, tonic, blood purifier and detoxifier agent. The present study was undertaken to investigate modulatory effects of walnut extract on the toxicity of an anticancer drug, cyclophosphamide (CP) with special reference to protection against disruption of drug metabolizing and antioxidant enzymes. Plant extract+CP group animals showed restoration in the level of cytochrome P450 (CYP) content and in the activities of glutathione S-transferase (GST), glutathione peroxidase (GP) and catalase (CAT) in both liver and kidneys. But plant extract restored the activity of superoxide dismutase (SOD) and the level of reduced glutathione (GSH) in the kidneys only when compared with CP-treated animals. Plant extract treatment alone caused significant reduction in the content of CYP in the kidneys mainly. The extract showed a significant increase in the level of GSH and in the activities of GP in both the tissues and CAT in liver only, whereas no significant change was observed in the activities of GST and SOD. CP treatment resulted in a significant (P < 0.01) increase in the lipid peroxidation (LPO) in the liver and kidneys compared with controls, while the extract+CP treated group showed a significant decrease in the LPO in liver and kidneys when compared with the CP-treated group. The study shows that the use of J. regia extract might be helpful in abrogation of CP toxicity during the chemotherapy.


Subject(s)
Antidotes/therapeutic use , Antineoplastic Agents, Alkylating/toxicity , Cyclophosphamide/toxicity , Juglans , Phytotherapy , Plant Extracts/therapeutic use , Poisoning/prevention & control , Animals , Antineoplastic Agents, Alkylating/antagonists & inhibitors , Chemoprevention , Cyclophosphamide/antagonists & inhibitors , Enzymes/drug effects , Enzymes/metabolism , Kidney/drug effects , Kidney/enzymology , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Male , Mice , Oxidative Stress/drug effects , Poisoning/etiology , Poisoning/metabolism
6.
Anesth Analg ; 97(3): 713-714, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12933391

ABSTRACT

Topical anesthesia using 60% lidocaine tape reduces the incidence of propofol injection pain. We conducted a randomized prospective double-blinded placebo-controlled study to assess the analgesic efficacy of pretreatment with topical 5% lidocaine-prilocaine (EMLA) cream in 90 ASA physical status I and II adult patients scheduled to undergo day-case gynecological surgery. Propofol injection pain was not reduced by pretreatment with EMLA cream, whereas the addition of lidocaine to propofol did significantly reduce propofol injection pain compared with the control group (P = 0.002). We conclude that topical anesthesia with EMLA cream applied for 60 min does not significantly reduce propofol injection pain.


Subject(s)
Anesthetics, Combined/administration & dosage , Anesthetics, Intravenous/adverse effects , Anesthetics, Local/administration & dosage , Injections, Intravenous/adverse effects , Lidocaine/administration & dosage , Pain/prevention & control , Prilocaine/administration & dosage , Propofol/adverse effects , Administration, Topical , Adolescent , Adult , Aged , Ambulatory Surgical Procedures , Double-Blind Method , Female , Gynecologic Surgical Procedures , Humans , Lidocaine, Prilocaine Drug Combination , Middle Aged , Ointments , Pain/etiology , Pain Measurement/drug effects
9.
Aquat Toxicol ; 49(4): 243-250, 2000 Jul 01.
Article in English | MEDLINE | ID: mdl-10854669

ABSTRACT

Pollutant-induced abnormal functioning of phagocytes and associated consequences were studied in freshwater catfish Heteropneustes fossilis (Bloch). Fish were exposed to effluent collected from bleached kraft type of paper mill at the concentration levels of 0.5, 1 and 2% for 15, 30, 60 and 90 days. Respiratory burst activity of peritoneal and head kidney phagocytes of exposed fish was measured by nitroblue tetrazolium reduction assay. Lipid peroxidation (LPO) was estimated in liver, gill and kidney of fish by measuring thiobarbituric acid reaction substances. It was observed that the phagocyte-activating xenobiotics of effluent induced an increase in the respiratory burst activity in phagocytes. The induction of respiratory burst activity was concomitantly associated with an increase in the peroxidative damage of tissues. The tissues most affected were kidney and gills. The change in LPO values in the gills of exposed fish was concentration- and time-dependent, showing significant increases (P<0.05 to <0.001) in all the exposed groups as compared with control fish. An almost similar pattern of LPO was observed in head kidney tissue (P<0.05 to <0.001). As regards liver, increase in LPO was not widespread, except at 0.5% for 90 days (P<0.05). In fact, reduced rates of LPO were observed in the livers of some groups. The results of respiratory burst corroborate with the phagocytic activation as well as with the extent of lipid peroxidation in the tissues, showing high population of circulatory phagocytes. Our results demonstrate that fish of polluted water are subjected to oxidative stress of multifarious dimensions.

SELECTION OF CITATIONS
SEARCH DETAIL
...